Error: Could not add to watchlist. X

Alnylam Pharmaceuticals Inc

+ Watchlist
ALNY:US
NASDAQ GS
102.91
USD
6.16
5.65%
As of 20:10:00 ET on 08/31/2015.
Open
116.96
Day Range
100.22 - 116.96
Volume
1,675,888
Previous Close
109.07
52Wk Range
63.48 - 140.00
1 Yr Return
47.71%
Open
116.96
Day Range
100.22 - 116.96
Volume
1,675,888
Previous Close
109.07
52Wk Range
63.48 - 140.00
1 Yr Return
47.71%
YTD Return
6.09%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.33
Market Cap (b USD)
8.708
Shares Outstanding (m)
84.615
Price/Sales (TTM)
131.18
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
ADDRESS
300 Third Steet
Cambridge, MA 02142
United States
PHONE
1-617-551-8200
  • John M Maraganore
    Chief Executive Officer
  • Barry E Greene
    President/COO
  • David-Alexandre Gros
    Senior VP/Chief Business Ofcr
  • Akshay K Vaishnaw
    Exec VP:Research & Dev
  • Laurie Bartlett Keating
    Senior VP/Secretary/Gen Cnsl
Show More